- Lymphoma
- Hematopathology
- Pediatric hematopathology
- +۴ مورد دیگر
Dr. Rebecca L. King is a Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic College of Medicine in Rochester, Minnesota. She serves as Program Director of the Hematopathology Fellowship Program and has held multiple leadership positions within professional societies including Treasurer of the Society for Hematopathology Executive Committee (2024-2026) and Interactive Microscopy Lead for the United States and Canadian Academy of Pathology. Dr. King completed her medical education at University of Pennsylvania School of Medicine (2007), followed by residency training in Anatomic and Clinical Pathology at Hospital of the University of Pennsylvania (2011), where she served as Chief Resident. She completed her Hematopathology Fellowship at Mayo Clinic College of Medicine in 2012. Her undergraduate studies were at Bucknell University where she earned a BS in Biology with a minor in Chemistry (2002). Her research focuses on lymphoma diagnostics and classification, with particular expertise in follicular lymphoma, diffuse large B-cell lymphoma, and rare lymphoid disorders. Dr. King has made significant contributions to lymphoma classification systems and has published extensively on the molecular characteristics of B-cell malignancies. Her work bridges diagnostic pathology with clinical outcomes, helping to refine lymphoma subtyping for improved patient care. She has been instrumental in developing consensus guidelines for lymphoma diagnosis and treatment through her involvement with the International Consensus Classification of Myeloid and Lymphoid Neoplasms. Dr. King's recent publications demonstrate a consistent focus on refining lymphoma classification systems, understanding treatment resistance mechanisms, and improving diagnostic criteria for various lymphoid malignancies. Her work spans molecular biology, clinical epidemiology, and diagnostic pathology, with an emphasis on translating research findings into practical clinical applications. She frequently collaborates with multidisciplinary teams to address complex diagnostic challenges in hematopathology. Among her notable recognitions are the Lodato Award for leadership, teaching, and contribution to the residency program (2011) and Alpha Omega Alpha Medical Honor Society membership (2007). She has received multiple undergraduate honors including Phi Beta Kappa and the President's Award for Distinguished Academic Achievement (2002). Dr. King actively mentors fellows and residents, having served as Mentor for Hematopathology and HemeOnc Fellow Conference (2014-2020) and as a member of the MCASOM Student Promotions and Assessment Committee. She co-directs Hematopathology Grand Rounds and contributes to multiple national guideline committees including the National Comprehensive Cancer Network B-cell lymphoma Guidelines Committee. Her leadership extends to the International Consensus Classification of Myeloid and Lymphoid Neoplasms as an Invited Contributor to the Clinical Advisory Committee. She maintains active involvement in multiple research initiatives including the Eastern Cooperative Oncology Group Lymphoma Core Committee and the European Association of Hematopathology, where she serves as Co-Chair. Her work on neurolymphomatosis, Richter transformation, and follicular lymphoma subtypes represents cutting-edge research at the intersection of diagnostic pathology and clinical oncology.








